• Filing Date: 2019-05-13
  • Form Type: 10-Q
  • Description: Quarterly report
v3.19.1
Condensed Consolidated Statement of Changes in Stockholders' Deficiency (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Series B Preferred Stock [Member]    
Beginning Balance
Beginning Balance, shares 100 100
Common stock issued upon exercise of warrants
Net loss
Other comprehensive loss  
Ending Balance
Ending Balance, shares 100 100
Common Stock [Member]    
Beginning Balance $ 384,615 $ 370,962
Beginning Balance, shares 384,614,528 370,961,451
Common stock issued upon exercise of warrants $ 100 $ 7,927
Common stock issued upon exercise of warrants, shares 100,000 7,926,739
Net loss
Other comprehensive loss  
Ending Balance $ 384,715 $ 378,889
Ending Balance, shares 384,714,528 378,888,190
Additional Paid-In Capital [Member]    
Beginning Balance $ 209,092,187 $ 208,351,431
Common stock issued upon exercise of warrants 5,230 414,568
Net loss
Other comprehensive loss  
Ending Balance 209,097,417 208,765,999
Accumulated Other Comprehensive Loss [Member]    
Beginning Balance  
Common stock issued upon exercise of warrants  
Net loss  
Other comprehensive loss (22,363)  
Ending Balance (22,363)  
Accumulated Deficit [Member]    
Beginning Balance (226,894,291) (218,741,236)
Common stock issued upon exercise of warrants
Net loss (1,369,830) (2,899,612)
Other comprehensive loss  
Ending Balance (228,264,121) (221,640,848)
Beginning Balance (17,417,489) (10,018,843)
Common stock issued upon exercise of warrants 5,330 422,495
Net loss (1,369,830) (2,899,612)
Other comprehensive loss (22,363)
Ending Balance $ (18,804,352) $ (12,495,960)